Trials / Active Not Recruiting
Active Not RecruitingNCT05688475
A Rollover Study of CC-122
Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating CC-122
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to provide CC-122 treatment to participants who have been receiving treatment in other CC-122 clinical trials investigating CC-122 for more than 5 years (CC-122-ST-001 \[NCT01421524\], CC-122-ST-002 \[NCT02509039\], CC-122-DBCL-001 \[NCT02031419\], and CC-122-NHL-001 \[NCT02417285\]), receiving clinical benefit from the treatment and to monitor the safety and tolerability of CC-122.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CC-122 | Specified dose on specified days |
| DRUG | Dexamethasone | Specified dose on specified days |
Timeline
- Start date
- 2023-04-11
- Primary completion
- 2026-02-25
- Completion
- 2026-02-25
- First posted
- 2023-01-18
- Last updated
- 2025-10-08
Locations
7 sites across 4 countries: United States, France, Japan, Netherlands
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05688475. Inclusion in this directory is not an endorsement.